BioSpace News Archive

The UltraDrape® Barrier and Securement Dressing decreases the risk of infection during ultrasound-guided peripheral IV (UGPIV) catheter insertions while reducing supply costs by 67 percent, according to a new study.

Vitalgenics Inc, a clinical stage biopharmaceutical company specializing in pancreatic cancer, has unraveled the etiology of pancreatic ductal adenocarcinoma (PDAC) with their FDA repurposed immunotherapy drug called Excindogen.

Aditxt, Inc. and SphereDX Launch AditxtScore ™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), today announced that it has selected Treatment-Resistant Depression (“TRD”) and End of Life Angst as initial target indications for its lead clinical candidate, MSP-1014.

Trinity Biotech plc today announced results for the quarter ended June 30, 2021.

Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, President, CEO and Chairman of the Board of Medicenna, will be presenting at the following virtual investor conferences to take place in September, 2021.

Nexa3D, the maker of ultrafast polymer 3D printers, announced that it partnered with functional polymers leader Henkel to produce the world’s first additively manufactured connected SKOP stethoscope for WeMed.

The Offering will consist of the issuance of an aggregate of up to 5,000,000 units (“Units”) at a price of $0.25 per Unit.

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that members of its executive management team are scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference.

Deepcell today announced the appointment of Kevin Jacobs as the Vice President of Bioinformatics.